8 results
P
women with recurrent miscarriages
I/C
hysteroscopic metroplasty
O
live-birth rate, clinical pregnancy rate, miscarriage rate
P
pregnant women
I/C
Vulvovaginal candidiasis (VVC), other studies worldwide
O
29.2%
P
patients
I/C
peripheral infusion of 3% HTS, central venous catheter (CVC)
O
complications
P
Methylmalonic aciduria (MMA) patients
I/C
Liver transplantation (LT), Combined liver and kidney transplantation (CLKT)
O
Patient survival, Graft survival, Biliary complications, Vascular complications, Rejection, Metabolic eradication, Kidney function normalization, Chronic kidney disease (CKD) remission, Neurodevelopmental status improvement, Protein intake liberalization
P
breast reconstruction
I/C
TUG flaps, abdominally based breast reconstruction
O
symmetrical aesthetically pleasant results
P
young patients
I/C
early clinical trials, different therapeutics, classical chemotherapy, immunochemotherapy, immunotherapy, Bruton-tyrosine kinase inhibitors, targeted approaches, cell-based therapies, combinatorial regimens
O
complete response rates, objective response rates, intension-to-treat failure rates
P
adult patients
I/C
vascular closure devices, extrinsic compression
O
hematoma, pseudoaneurysm, bleeding, minor and major vascular complications, time to hemostasis, device failure
P
Staphylococcus aureus, Escherichia coli, S. epidermis
I/C
Omniflow II biosynthetic vascular grafts
O
early graft occlusion, early graft stenosis, reinfection